SA
Go ProLog In
TIL
OverviewIntelligenceChart
Q3 2026 EPS Estimate
$-0.35
Reports before open

Analyst Sentiment

Wall St. Consensus
Hold
7 analysts·Limited coverage
61
Score
3 Buy (43%)4 Hold (57%)0 Sell (0%)
Rating Breakdown
Strong Buy
00%
Buy
343%
Hold
457%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear
$7.00
-14.4%
Consensus
$7.00
-14.4%
Bull
$7.00
-14.4%
12-Month Target Range7 analysts
$7.00$7.00$7.00
Current $8.18Consensus
Current Price
$8.18
Above Consensus
$1.18

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

No analyst estimates available

Earnings Surprises

Earnings surprise history unavailable.

Recent Analyst Actions

Jan 6, 2026Robert W. Baird
Instil Bio downgraded to Neutral from Outperform at Baird
Target:$7.00
+7.4%from $6.52
Sep 16, 2024Robert W. Baird
Baird Reiterates Outperform Rating on Instil Bio Inc (TIL)
Target:$180.00
+174.5%from $65.58
Sep 16, 2024H.C. Wainwright
Instil Bio Inc (TIL) PT Raised to $120 at H.C. Wainwright
Target:$120.00
+42.0%from $84.52
Sep 12, 2024H.C. Wainwright
Instil Bio Inc (TIL) PT Raised to $40 at H.C. Wainwright
Target:$40.00
+2.1%from $39.19
Apr 12, 2024Jefferies
Jefferies Downgrades Instil Bio Inc (TIL) to Hold, 'Company Exploring New Avenues Beyond TILs'
Target:$11.00
-0.5%from $11.06
Dec 12, 2022Morgan Stanley
Morgan Stanley Maintains Equal-Weight on Instil Bio, Lowers Price Target to $2
Target:$2.00
+138.3%from $0.84
Jun 5, 2022Morgan Stanley
Instil Bio price target lowered to $9 from $14 at Morgan Stanley
Target:$9.00
+49.8%from $6.01

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance